https://www.bioworld.com/rss en-us http://www.bioworld.com/articles/730470 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730470-xuanzhu-shares-dip-despite-phase-iii-alk-inhibitor-data Lung cancer illustration http://www.bioworld.com/articles/730468 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730468-novos-forma-acquisition-pays-off-with-mitapivat-competitor Sickle cell illustration http://www.bioworld.com/articles/730465 Mon, 20 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730465-psychedelic-space-expanding-on-trumps-eo Green arrow on blue abstract background http://www.bioworld.com/articles/730390 Mon, 20 Apr 2026 08:00:00 -0400 https://www.bioworld.com/articles/730390-storm-raises-56m-series-c-for-phase-ii-rna-inhibitor-trial-in-sarcoma Blue dollar sign on white background http://www.bioworld.com/articles/730406 Fri, 17 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730406-delta-fly-eyes-nda-path-despite-aml-phase-iii-miss Acute myeloid leukemia illustration BioWorld data.]]> http://www.bioworld.com/articles/730403 Fri, 17 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730403-obesity-focused-kailera-goes-for-us-biopharma-record-with-625m-ipo Gold IPO with chart http://www.bioworld.com/articles/730389 Thu, 16 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730389-lillys-glp-1-foundayo-aces-mace-in-dili-of-a-phase-iii Foundayo Credit: Eli Lilly and Co. http://www.bioworld.com/articles/730311 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730311-pricing-standoff-leaves-australian-patients-in-limbo White tablet imprinted with dollar sign http://www.bioworld.com/articles/730308 Wed, 15 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730308-revolution-medicines-15b-follow-on-highest-to-date Dollar sign on financial stock market chart background http://www.bioworld.com/articles/730419 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730419-everest-to-acquire-singapore-unit-of-hasten-bio-in-250m-deal Handshake behind digital globe http://www.bioworld.com/articles/730418 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730418-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730297 Tue, 14 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730297-abbvie-nabs-two-nav18-pain-projects-from-haisco-in-745m-deal Open capsule delivering pain relief to body http://www.bioworld.com/articles/730293 Tue, 14 Apr 2026 08:00:00 -0400 https://www.bioworld.com/articles/730293-traveres-filspari-approved-for-rare-kidney-disease-fsgs Kidneys, pills and chart line http://www.bioworld.com/articles/730277 Mon, 13 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730277-revolutions-daraxonrasib-nails-endpoints-in-pancreatic-cancer-trial 3D pancreas illustration http://www.bioworld.com/articles/730421 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730421-fda-accepts-telixs-resubmitted-nda-for-brain-imaging-agent Brain scans http://www.bioworld.com/articles/730225 Fri, 10 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730225-fda-accepts-telixs-resubmitted-nda-for-brain-imaging-agent Brain scans Pharma Annual Review 2026, published by Pharmaprojects, a firm that tracks global pharma R&D.]]> http://www.bioworld.com/articles/730343 Fri, 10 Apr 2026 09:00:00 -0400 https://www.bioworld.com/articles/730343-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730212 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730212-everest-to-acquire-singapore-unit-of-hasten-bio-in-250m-deal Handshake behind digital globe http://www.bioworld.com/articles/730211 Thu, 09 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730211-biologics-in-development-outnumber-small-molecules-for-the-first-time Drug research illustration http://www.bioworld.com/articles/730134 Tue, 07 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730134-amplia-halts-enrollment-in-phase-ii-pancreatic-cancer-trial Illustration of cancer in the pancreas http://www.bioworld.com/articles/730204 Tue, 07 Apr 2026 11:00:00 -0400 https://www.bioworld.com/articles/730204-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/730118 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730118-one-carbon-has-new-approach-to-starving-tumors-of-nucleotides Blue cancer cell http://www.bioworld.com/articles/730115 Mon, 06 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730115-vykat-caveat-neurocrines-29b-soleno-bid-low-ball Vykat XR Credit: Soleno Therapeutics Inc. http://www.bioworld.com/articles/730074 Thu, 02 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/730074-lhon-updates-gene-therapy-progress-idebenone-receives-us-crl Eye and DNA illustration http://www.bioworld.com/articles/729982 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729982-wegovy-pricing-deal-offers-uk-reimbursement-for-heart-disease Wegovy Credit: Novo Nordisk A/S http://www.bioworld.com/articles/729980 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729980-five-drug-vipor-regimen-shows-promise-in-aggressive-blood-cancer PET scans showing before and after treatment with VIPOR Before (top) and after (bottom) treatment with VIPOR. Full-body and cross-sectional PET scans of a patient show large lymphoma tumors (circled in red) that have disappeared with treatment. Credit: Center for Cancer Research/National Cancer Institute http://www.bioworld.com/articles/729976 Wed, 01 Apr 2026 12:00:00 -0400 https://www.bioworld.com/articles/729976-lillys-foundayo-enters-oral-glp-1-obesity-market-with-speedy-fda-nod Eli Lilly logo atop Lilly Biotechnology Center campus in San Diego, Calif. Credit: MichaelVi - stock.adobe.com http://www.bioworld.com/articles/730091 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730091-lilly-taps-insilico-ai-in-275b-deal-to-expand-pipeline-options Pill in immersive interface http://www.bioworld.com/articles/730090 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730090-otsuka-to-acquire-ptsd-drugmaker-transcend-in-12b-deal Brain with handshake and cityscape http://www.bioworld.com/articles/730087 Tue, 31 Mar 2026 12:00:00 -0400 https://www.bioworld.com/articles/730087-korea-roundup-alteogen-celltrion-lead-biotech-deals Seo Jin-seok of Celltrion (right) with Ko Kwang-pyo of Kobiolabs (left) Seo Jin-seok, CEO, Celltrion (right) with Ko Kwang-pyo, founder and CEO, Kobiolabs (left).